Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis.

Cheng, Chunliang; Qiu, Dongxu; Chen, Jinbo; Zu, Xiongbing; Liu, Jinhui; Li, Huihuang; Hu, Jiao; Yi, Zhenglin; He, Tongchen; Chen, Zhi; Cui, Yu

Cheng, Chunliang; Qiu, Dongxu; Chen, Jinbo; Zu, Xiongbing; Liu, Jinhui; Li, Huihuang; Hu, Jiao; Yi, Zhenglin; He, Tongchen; Chen, Zhi; Cui, Yu.

Afiliação

Cheng C; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Qiu D; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Chen J; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Zu X; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Liu J; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Li H; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Hu J; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Yi Z; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
He T; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Chen Z; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Cui Y; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.

Front Pharmacol ; 12: 707271, 2021.

Article em En | MEDLINE | ID: mdl-34603020

Palavras-chave

high-risk non-muscle-invasive bladder cancer; intra-arterial chemotherapy; intravesical chemotherapy; progression; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google